- Home
- ALDX vs BYM Comparison
ALDX vs BYM Comparison
Compare ALDX & BYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- BYM
- Stock Information
- Founded
- ALDX 2004
- BYM 2002
- Country
- ALDX United States
- BYM United States
- Employees
- ALDX N/A
- BYM N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- BYM Investment Managers
- Sector
- ALDX Health Care
- BYM Finance
- Exchange
- ALDX Nasdaq
- BYM Nasdaq
- Market Cap
- ALDX 342.3M
- BYM 281.6M
- IPO Year
- ALDX 2014
- BYM N/A
- Fundamental
- Price
- ALDX $5.39
- BYM $11.01
- Analyst Decision
- ALDX Strong Buy
- BYM
- Analyst Count
- ALDX 2
- BYM 0
- Target Price
- ALDX $9.50
- BYM N/A
- AVG Volume (30 Days)
- ALDX 772.4K
- BYM 60.2K
- Earning Date
- ALDX 11-06-2025
- BYM 01-01-0001
- Dividend Yield
- ALDX N/A
- BYM 4.49%
- EPS Growth
- ALDX N/A
- BYM N/A
- EPS
- ALDX N/A
- BYM N/A
- Revenue
- ALDX N/A
- BYM N/A
- Revenue This Year
- ALDX N/A
- BYM N/A
- Revenue Next Year
- ALDX $43.00
- BYM N/A
- P/E Ratio
- ALDX N/A
- BYM N/A
- Revenue Growth
- ALDX N/A
- BYM N/A
- 52 Week Low
- ALDX $1.14
- BYM $9.30
- 52 Week High
- ALDX $7.20
- BYM $11.77
- Technical
- Relative Strength Index (RSI)
- ALDX 45.98
- BYM 73.09
- Support Level
- ALDX $5.48
- BYM $10.50
- Resistance Level
- ALDX $5.88
- BYM $11.09
- Average True Range (ATR)
- ALDX 0.27
- BYM 0.10
- MACD
- ALDX -0.07
- BYM 0.05
- Stochastic Oscillator
- ALDX 1.87
- BYM 88.41
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About BYM Blackrock Municipal Income Quality Trust of Beneficial Interest
Blackrock Municipal Income Quality Trust is a closed-end municipal bond fund. Its investment objective is to provide current income exempt from U.S. federal income taxes, including the alternative minimum tax. The trust invests in various sectors such as transportation, utilities, health, education, corporate, housing, and others.